Affimed N.V. Total Non Current Liabilities 2011-2026 | AFMD

Annual Total Non Current Liabilities Affimed N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	36.7 M	38.5 M	39.2 M	4.09 M	3.62 M	3.1 M	3.9 M	90.8 M	78.2 M	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
90.8 M	3.1 M	33.1 M

Quarterly Total Non Current Liabilities Affimed N.V.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	16.1 M	-	24.6 M	-	30 M	-	36.7 M	-	28.2 M	-	38.5 M	-	39.7 M	-	39.2 M	-	-	-	4.09 M	-	-	-	3.62 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
39.7 M	3.62 M	26.1 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Adagene ADAG	158 M	$ 2.38	17.22 %	$ 134 M	China
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
BioLineRx Ltd. BLRX	8.22 M	$ 2.99	0.74 %	$ 908 M	Israel
BioNTech SE BNTX	341 M	$ 115.72	-2.32 %	$ 27.2 B	Germany
BioXcel Therapeutics BTAI	1.4 M	$ 1.82	0.55 %	$ 4.61 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.31	1.22 %	$ 7.96 B	Australia
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 4.4	5.77 %	$ 9.57 B	Israel
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 25.88	-1.01 %	$ 1.25 B	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	10.2 M	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Athira Pharma ATHA	876 K	-	-	$ 269 M	USA
Corcept Therapeutics Incorporated CORT	2.29 M	$ 43.14	4.46 %	$ 4.45 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Catalyst Pharmaceuticals CPRX	648 K	$ 23.9	-2.27 %	$ 2.83 B	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Ascendis Pharma A/S ASND	101 M	$ 231.39	1.2 %	$ 5 B	Danmark
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Aytu BioScience AYTU	42.1 M	$ 2.72	0.18 %	$ 17.1 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Arrowhead Pharmaceuticals ARWR	686 M	$ 68.21	-1.98 %	$ 9.12 B	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Coherus BioSciences CHRS	189 M	$ 2.05	28.93 %	$ 193 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Biogen BIIB	9.03 B	$ 171.06	-1.58 %	$ 24.9 B	USA
Bio-Path Holdings BPTH	236 K	-	-	$ 100 K	USA
BioVie BIVI	62.5 K	$ 1.24	-0.8 %	$ 1.83 M	USA
Baudax Bio BXRX	65.4 M	-	0.59 %	$ 63 K	USA
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA